Stay updated on Pembrolizumab in SCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in SCLC Clinical Trial page.

Latest updates to the Pembrolizumab in SCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows a new revision tag 'Revision: v3.6.4', replacing the previous 'Revision: v3.6.3'. This indicates a small update to the page version without changing the study information or content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe page shows a new revision label (v3.6.3) replacing the previous v3.6.2, indicating a deployment/update of the page build without altering study content.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page revision indicator was updated to v3.6.2, replacing the previous v3.6.0. This indicates a minor internal update to the page template or content.SummaryDifference0.1%

- Check55 days agoChange DetectedRecruitment status on the page now shows 'No longer looking for participants,' and the Intervention/Treatment label has been standardized. New help and navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, and the revision tag updated to v3.6.0.SummaryDifference0.5%

- Check62 days agoChange DetectedThe page revision label updated from v3.5.4 to v3.5.5, indicating a refreshed version of the page.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new version of the page content has been published.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in SCLC Clinical Trial page.